###### Article summary

Article focus
=============

-   Long-term clinical outcomes after cataract surgery with and without capsular tension ring in a group of patients with retinitis pigmentosa.

Key messages
============

-   Both surgical approaches were beneficial to patients with retinitis pigmentosa.

-   Surgery with capsular tension ring implantation resulted in fewer long-term postoperative complications including secondary cataract and capsular contraction syndrome.

Strengths and limitations of this study
=======================================

-   Relatively small sample size of this special subset of cataract patients.

Introduction {#s1}
============

The development of cataract is a well-known complication seen in patients with retinitis pigmentosa (RP).[@R1; @R2; @R3; @R4] Treatment essentially involves phacoemulsification of the natural lens and the replacement by an artificial one. Relatively minor lens opacities may cause disproportionate functional symptoms, keeping in mind the inferior retinal function. In general, RP is an important cause of blindness among working-age people.[@R1] Cataract surgery led to an increase of contrast and helped this patient group gain visual acuity. Cut-off filters may be used to improve contrast sensitivity.[@R2] Although, a steady decrease is anticipated in the long-term perspective, surgical intervention is recommended, necessary to improve quality of life. Some different types of surgical add-ons have been described in the literature to approach the potential postoperative complications, one of them being the capsular contraction syndrome (CCS).[@R5] Whether to utilise them remains to the surgeon\'s preference. This retrospective study tried to compare the development of short-term and long-term postoperative complications and the best corrected visual acuity (BCVA) between two different groups. Group 1 received phacoemulsification and the implantation of an intraocular lens (IOL, type 1 surgery). In group 2 a capsular tension ring (CTR) was added to the inserted IOL (type 2 surgery). The postoperative complications taken into consideration were intraocular pressure (IOP), cystoid macular oedema (CME), secondary cataract and CCS. The former two may be treated medically, whereas the latter two ask for surgical intervention.

Patients and methods {#s2}
====================

The data of 46 patients with RP who had cataract removal and phacoemulsification with or without subsequent CTR implantation were retrospectively reviewed. A research was conducted according to the tenets of the Declaration of Helsinki and with the approval of the ethics committee of Tuebingen. The first group (26 eyes) had phacoemulsification and IOL implantation. In the second group (26 eyes) a CTR was additionally inserted. The surgical technique involved temporally localised clear corneal incision with 2.75 mm of wound size. The experienced surgeons operated this kind of demanding cataract with the risk of zonulolysis using the stop and chop technique in advanced nuclear opacity and the chip and flip technique in soft cataracts. Excessive cleaning of the posterior capsule, the equatorial bag and the anterior undersurface was performed in all cases. The IOL types used were all hydrophobic, acrylic lenses made up of a single piece or multipiece. In group 1, 1 and 25 have three-piece or one-piece IOLs, respectively. In group 2, 10 and 16 have three-piece or one-piece IOLs, respectively. The CTR type was either Croma-Pharma GmbH (Leobendorf, Austria) or Morcher GmbH (Stuttgart, Germany) fabricate of 11 mm. There were 19 emmetropic, 6 myopic and 27 hyperopic eyes. Ophthalmological examinations were performed prior to surgery and at the follow-up visits. Examinations included the assessment of IOP by Goldmann tonometry, BCVA, anterior chamber, vitreal and retinal statuses. Surgeries took place between October 2002 and May 2010. Sex, age at surgery, preoperative findings, associated diseases, length of follow-up and postoperative complications were documented. Complications included IOP increase, CME, secondary cataract and CCS. The BCVA was determined by the use of Early Treatment Diabetic Retinopathy Study (ETDRS) charts, converted into logarithm of the minimal angle of resolution (LogMAR) units and recorded at the immediate preoperative visit and postoperative follow-up examinations.

Perioperative management {#s3}
========================

Preoperatively patients received antibiotics (fluoroquinolones four times daily) and corticosteroids (0.1% dexamethasone gel four times daily) at least 24 h prior to surgery. Postoperatively the medications were continued for up to 2 weeks or tapered, respectively.

Statistical analysis {#s4}
====================

The analysis was undertaken using the commercial software (JMP V.9.0). Results have been presented, with 95% CIs. Nominal p values were calculated using t test and the level of significance was set at 0.05.

Results and patient characteristics {#s5}
===================================

The mean age at surgery of our 29 male and 23 female patients was 53 years and ranged between 21 and 89 years. The overall mean follow-up time was 26 months (range 3--60 months). In group 1 the mean follow-up period was 28 months (range 3--52 months) and in group 2, it was 24 months (range 3--60 months). The most common complication was secondary cataract occurring in 44% (23 eyes) followed by increased IOP (requiring treatment, 10%; 5 eyes), CCS (4%, 2 eyes) and CME (4%, 2 eyes). Group 1 exhibited 13 eyes (50%) with secondary cataract, 4 eyes (15%) with IOP elevation, and 2 eyes (8%) with CCS and CME, respectively. Group 2 displayed 10 eyes (38%) with secondary cataract and 1 (4%) with CME and elevated IOP, respectively.

Visual outcome {#s5a}
--------------

The group exhibited 19 eyes (37%) with unchanged BCVA, 6 eyes (12%) with a decrease and 27 eyes (52%) with an increase of the BCVA. The mean preoperative LogMAR BCVA in the entire group was 1.45 ± 0.85 (95% CI 1.21 to 1.69) and increased to 1.32 ± 0.95 (95% CI 1.06 to 1.58, p=0.02). The mean preoperative and the mean postoperative LogMAR BCVA in the non-CTR group improved from 1.16 ± 0.8 (95% CI 0.83 to 1.48) to 0.98 ± 0.88 (95% CI 0.62 to 1.33, p=0.02) and in the CTR group from 1.74 ± 0.81 (95% CI 1.42 to 2.07) to 1.66 ± 0.90 (95% CI 1.3 to 2.03, p=0.31), respectively. The preoperative and postoperative overviews are shown in [figure 1](#BMJOPEN2013002616F1){ref-type="fig"}.

![Preoperative and postoperative vision of the logarithm of the minimal angle of resolution (LogMAR) for the total group, types 2 and 1 surgeries.](bmjopen2013002616f01){#BMJOPEN2013002616F1}

Complications {#s5b}
-------------

The postoperative complications included secondary cataract, increased IOP, CCS and CME in order of occurrence. An overview of the postoperative complications is given in [figure 2](#BMJOPEN2013002616F2){ref-type="fig"}. In comparison, secondary cataract was seen in 50% of cases in group 1 and 38% of the cases in group 2. Concerning CCS all cases were observed in group 1 and no cases in group 2. The increase in IOP was noted in 15% of cases in group 1 and 4% of cases in group 2. During the follow-up period one patient of group 1 developed subluxated IOL on her right eye and several years later on her left eye. Explantation and implantation of a scleral-fixed lens was performed ([figures 3](#BMJOPEN2013002616F3){ref-type="fig"} and [4](#BMJOPEN2013002616F4){ref-type="fig"}). A decreased rate of secondary cataract and CCS was noted in group 2. Secondary cataract was seen in 10 eyes in group 2 and 13 eyes in group 1 (p=0.4). CCS was only seen in the group which received type 1 surgery ([figure 5](#BMJOPEN2013002616F5){ref-type="fig"}; p=0.15).

![Overview of the postoperative complications.](bmjopen2013002616f02){#BMJOPEN2013002616F2}

![Demonstrates the intraocular lens (IOL) dislocation of one patient with bilateral severe zonular insufficiency.](bmjopen2013002616f03){#BMJOPEN2013002616F3}

![Scleral-fixed IOL of one patient with bilateral severe zonular insufficiency.](bmjopen2013002616f04){#BMJOPEN2013002616F4}

![Depicts the developed capsular phimosis in a patient belonging to group 1, which did not receive additional capsular tension ring insertion.](bmjopen2013002616f05){#BMJOPEN2013002616F5}

Discussion {#s6}
==========

Cataract is a common complication in patients with RP. The common form is the posterior subcapsular cataract found among all genetic subtypes.[@R3] [@R4] Fortunately the treatment is straightforward and involves cataract surgery. This procedure may be of great benefit to the patient, keeping in mind the inferior retinal function ([figure 6](#BMJOPEN2013002616F6){ref-type="fig"}). An improvement of the quality of life is a consequence. Nevertheless, the potential postoperative complications may be frustrating.[@R6] To address these, additional implantable devices were conceived.[@R5] Whether to utilise them remains up to the surgeon\'s preference. This retrospective study tried to compare the BCVA and the development of short-term and long-term postoperative complications after cataract surgery with and without the implantation of a CTR. Type 1 surgery included phacoemulsification and the implantation of an IOL. Type 2 surgery adds a CTR to the inserted IOL. Postoperative complications taken into consideration were IOP, CME, secondary cataract and CCS.[@R3] [@R4] [@R7; @R8; @R9; @R10; @R11; @R12; @R13; @R14] The most common complication was secondary cataract occurring in 44% (23 eyes) followed by increased IOP (10%, 6 eyes), CCS (4%, 2 eyes) and CME (4%, 2 eyes). Comparing both groups less cases of secondary cataract and CCS could be observed in group 2. The mean preoperative and mean postoperative LogMAR BCVA improved in both groups, although in group 2 the difference was not statistically significant. Group 1 performed better in terms of the final vision. This might be explained by the decreased, preoperative visual acuity of group 2. Thus, both surgical approaches had beneficial outcomes for our patients in terms of a low rate of postoperative complications or increased visual acuity. The decreased number of eyes requiring IOP-lowering therapy in group 2 was considered a coincidence. Five eyes received antiglaucoma therapy. We had no straightforward explanation for this observation. In one case with bilateral subluxated IOL severe zonular insufficiency, noted intraoperatively, was suspected as the cause.[@R14; @R15; @R16]

![Pathognomonic retinal changes in a retinitis pigmentosa patient.](bmjopen2013002616f06){#BMJOPEN2013002616F6}

The additional implantation of a CTR may prevent IOL decentralisation/subluxation, posterior capsule opacification and anterior capsular phimosis as reported by other groups.[@R15] [@R17] [@R18] A decrease of posterior capsular opacification was also observed. Rapid capsular phimosis may especially occur in patients with RP.[@R19] Precautions like CTRs should therefore be considered.[@R5] [@R18] Ahmed and colleagues reported improvements in CTR technology enhancing the safety and efficiency in eyes with profound zonular instability. In addition scleral-fixed devices may aid even more in decreasing intraoperative and postoperative risks.[@R5] Nevertheless, there are also reports in the literature stating fibrotic reactions, regarding PCO and CCS, and dislocations in patients with zonular weakness.[@R20; @R21; @R22]

The limitations of the current study may be the relatively small sample size of this special subset of cataract patients. Further studies may try to include more cases or an analysis of the different genetic subtypes of RP. It may be concluded that less cases of secondary cataract and CCS could be observed in group 2 and that both surgical approaches had beneficial outcomes for our patients in terms of increased visual acuity or decreased postoperative complications.
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